InMed Pharmaceuticals
INM1.3300.00% ( 0.000 )
Q4 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: InMed Pharmaceuticals(INM) the EBIT is -3.211 M (-70.04%);the EPS is -1.33 (-11.34%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B70.04%
----
----
EPS
-1.334711.34%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf